Vimarsana
Biggest News Aggregation in the World

David Zacks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Zacks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Zacks Today - Breaking & Trending Today

ARVO Foundation Names 2023 Recipient of Kreissig Award for Excellence in Retinal Surgery - Vimarsana News

ARVO Foundation Names 2023 Recipient of Kreissig Award for Excellence in Retinal Surgery

Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates David Zacks, MD, PhD — 2023 recipient of the Kreissi

At-Home Monitoring for Age-Related Macular Degeneration Gets High Marks - Vimarsana News

At-Home Monitoring for Age-Related Macular Degeneration Gets High Marks

No change in visual acuity, office-visit interval almost doubled during 6 months

5 Key Takeaways | The Lawyer's Obligations to Ethical Conduct and Professionalism in Negotiations and Mediations | Kilpatrick Townsend & Stockton LLP - Vimarsana News

5 Key Takeaways | The Lawyer's Obligations to Ethical Conduct and Professionalism in Negotiations and Mediations | Kilpatrick Townsend & Stockton LLP

Kathleen Barton, Brian Gaudet, and David Zacks recently participated in a panel at the annual Susan A. Cahoon Annual Ethics and Professionalism Seminar hosted by Kilpatrick Townsend....

5 Key Takeaways - The Lawyer's Obligations to Ethical Conduct and Professionalism in Negotiations and Mediations | Kilpatrick Townsend & Stockton LLP - Vimarsana News

5 Key Takeaways - The Lawyer's Obligations to Ethical Conduct and Professionalism in Negotiations and Mediations | Kilpatrick Townsend & Stockton LLP

Kilpatrick Townsend’s Brian Gaudet and Katie Barton and David Zacks of Zacks Resolution recently participated in a panel at the annual Susan A. Cahoon Annual Ethics and Professionalism...

ONL Therapeutics Closes 2nd Tranche of $46.9M Series B Financing - Vimarsana News

ONL Therapeutics Closes 2nd Tranche of $46.9M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!